Oral anticancer drugs: back to square one.

Szmulewitz and Ratain expressed concerns in their article "Playing Russian Roulette With Tyrosine Kinase Inhibitors," published in the March 2013 issue. This Commentary is intended to add emphasis to the concerns they raised as well as to draw the attention of the clinical pharmacology community to additional critical issues related to oral administration of modern anticancer medication.